Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05610241
Other study ID # CI52248
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 4, 2023
Est. completion date March 21, 2023

Study information

Verified date September 2023
Source DeRoyal Industries, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Compression wraps treat venous leg ulcers when applied correctly. Often, clinicians apply the wraps at the wrong compression, or the wrap loosens, stopping clinical benefits. The study aims to show the feasibility of a smart compression prototype to maintain a set compression level in healthy volunteers. Each volunteer will wear the prototype device on one leg and a standard compression wrap on the other. Volunteers will pump their calves, walk, lie down, and stand at zero, one, and four hours. A pressure sensor placed over each calf will record the compression level during the activities. Volunteers will provide subjective feedback on each device concerning comfort and usability. After four hours, researchers will remove the standard wrap. Volunteers will use the prototype device during daily activities for three days. During the three days, the volunteers will complete a daily journal. The journal will capture the user experience and time the volunteer used the device. A final site visit allows researchers to conduct exit interviews and download the history of applied compression. Researchers will use the data to show that the prototype device maintains therapeutic compression and prove the usability of the device.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date March 21, 2023
Est. primary completion date March 18, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Intact, healthy skin at the application site in both legs - Calf circumferences to be within 30 - 50 cm between the medial and lateral head of the gastrocnemius - Able to understand the Patient Information Leaflet - Willing and able to give informed consent - Able to wear, don and doff the compression device without external help - Willing and able to follow the requirements of the clinical investigation plan - Presence of pedal pulses identified by hand-held Doppler (8 MHz) - Ankle Brachial Pressure Index between 0.9 and 1.4 Exclusion Criteria: - History of signs of previous deep or superficial vein thrombosis/pulmonary embolism - Peripheral artery disease ( or ABPI < 0.90 or > 1.4), critical limb ischemia, or arterial ulceration - Varicose veins, varicose eczema, or venous ulceration - Chronic lower limb swelling, edema, lymphedema, or lipoedema - Recent surgery within the last three months (such as abdominal, gynecological, hip or knee replacement, or lower limb) that may affect the study in the opinion of the investigator - Recent trauma to a lower limb within the last three months - Chronic obesity (defined as BMI index >40 kg/m^2) - Diabetes mellitus - Pregnancy - A pulse rate of fewer than 40 beats/minute - A sitting systolic blood pressure of > 180 and < 100 mmHg and/or a sitting diastolic pressure of > 100 mmHg - Any significant illness during the previous four (4) weeks - Participation in any clinical study during the eight (8) weeks preceding the screening period - Any evidence of edema or pain - Skin diseases, including wounds on the feet or lower limbs - Any history of heart, liver, kidney, or vascular diseases - History of having been prescribed compression stockings for treatment of a medical condition - Serious allergies - Dermatitis with oozing or fragile skin - Persons currently using NSAID, Diuretics, Vasodilators, and steriods - Drivers and Driving Professionals

Study Design


Intervention

Device:
Compression Therapy System Prototype
A device designed to deliver compression therapy at a pre-set level to the lower leg for legs with a circumference between 30-50 cm. The device provides compression through a series of three air bladders and is controlled by a battery-powered electronic module that controls compression levels by monitoring bladder pressure.
Standard Compression
Coban 2 represents the standard of care 2-layer compression wrap used to treat venous leg ulcers. The device consists of a comfort layer and a compression layer. A clinician applies the device to establish compression therapy.

Locations

Country Name City State
Ireland RCSI Education and Research Centre Dublin

Sponsors (4)

Lead Sponsor Collaborator
DeRoyal Industries, Inc. Enterprise Ireland, Royal College of Surgeons, Ireland, Tyndall National Institute

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Apply Intervention by clinician The time it takes a clinician to place the assigned intervention to each limb Measured on Day 0
Primary Time to Apply compression therapy prototype by volunteer The time it takes the volunteer to place the assigned intervention to each limb Measured on Day 0
Primary Interface Pressure after Application of Intervention Interface pressure measured by pressure sensor (Pico Press) following application by research clinician Measured on Day 1
Primary Average Interface Pressure during Walking The participant walks on a treadmill for 10 minutes. A pressure sensor (Pico Press) continuously measures compression at the medial gastrocnemius head. The interface pressure measurements are averaged over ten minutes of data collection. The analysis compares changes in pressure over the three measurements for each intervention. Measured at 0 hours, 1 hour, and 4 hours on Day 1
Primary Average Interface Pressure during Calf Pumping The participant pumps each calf independently for 30 seconds. A pressure sensor (Pico Press) continuously measures compression at the medial gastrocnemius head. The interface pressure measurements are averaged over 30 seconds of data collection. The analysis compares changes in pressure over the three measurements for each intervention. Measured at 0 hours, 1 hour, and 4 hours on Day 1
Primary Average Interface Pressure during Standing The participant stands for 30 seconds. A pressure sensor (Pico Press) continuously measures compression at the medial gastrocnemius head. The interface pressure measurements are averaged over 30 seconds of data collection. The analysis compares changes in pressure over the three measurements for each intervention. Measured at 0 hours, 1 hour, and 4 hours on Day 1
Primary Average Interface Pressure while laying down The participant lays down on the bed for 30 seconds. A pressure sensor (Pico Press) continuously measures compression at the medial gastrocnemius head. The interface pressure measurements are averaged over 30 seconds of data collection. The analysis compares changes in pressure over the three measurements for each intervention. Measured at 0 hours, 1 hour, and 4 hours on Day 1
Primary Accuracy of Compression Therapy System Prototype compared to Interface Pressure During data collection on day 1, the pressure sensor (Pico Press) will continuously monitor compression level applied to the calf. Researchers willl compare the pressure applied from the device to the measured pressure at the calf. Measured between 0 and 4 hours on day 1
Primary Visual Analogue Sensory (Pain) Assessment Pain assessment completed by a 0 to 10 visual analog scale where 0 represents no pain and 10 represents severe pain. Measured on Day 1 at hour 4
Primary Visual Analogue Skin Redness Assessment Visual Analogue Scale between 0 (no redness) to 10 (severe redness) Measured on Day 1 at hour 4 for both interventions; Measured on Day 2 - 4 for Compression Therapy System Prototype
Primary Usability Assessment Questionnaire that allows research participants to score each intervention on a 1 (Strongly disagree) to 5 (Strongly agree) scale for the following questions:
The intervention stayed in place while you are wearing it. The appearance of the intervention is aesthetically appealing The dimensions of the intervention are appropriate The weight of the intervention is comfortable when wearing it Overall I was able to successfully use the compression therapy prototype The user manual is helpful for me in managing the compression therapy prototype The instructions in the user manual are understandable (compression therapy prototype only) Overall, the Compression Therapy System Prototype is user friendly Overall, I feel comfortable when I use the intervention Overall, I feel confident when I use the intervention Overall I feel there is no risk to me when I use the intervention
Completed on Day 1 for both interventions and daily on Day 2, 3, and 4 for the compression therapy system prototype
Primary At home usability assessment Questions will be asked to healthy volunteers during three day period at home. Volunteers rate their response on a scale from 1 (strongly disagree) to 5 (strongly agree).
I learned to use the compression therapy prototype quickly I learned to use the compression therapy prototype easily I easily remember how to use the compression therapy prototype I quickly became skillful with the compression therapy prototype It isn't necessary to have too much previous knowledge to use the compression therapy prototype The instructions for use are clear and easy to understand
The LED signs from the compression therapy prototype is accurate Overall, I was able to successfully interpret the LED signs of the compression therapy prototype The LED signs of the compression therapy prototype are understandable and easy to interpret The LED signs were helpful for me in managing the compression therapy prototype The LED signs allow me to correct mistakes quickly and easily
Day 2 and 3
See also
  Status Clinical Trial Phase
Completed NCT03903692 - A Comparative Evaluation of a MPS Dressing and a CMC Dressing on Subjects With Lower Extremity Venous Ulcers N/A
Completed NCT03257254 - Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU)
Recruiting NCT03666754 - Early Glue Saphenous Vein Ablation With Compression Versus Compression Alone in the Healing of the Venous Ulcer N/A
Withdrawn NCT02912858 - Intermittent Pneumatic Compression of the Foot vs Geko Plus R-2 Neuromuscular Electrostimulation Device in Venous Leg Ulcer Patients N/A
Completed NCT02482038 - Geko Venous Leg Ulcer Study N/A
Completed NCT02652572 - Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers Phase 1
Unknown status NCT01658618 - Safety Study Providing 12 Months Follow-up From First Exposure to HP802-247 in Subjects With Venous Leg Ulcer N/A
Completed NCT05646121 - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Completed NCT03077165 - Dose-response Relationship Study of S42909 on Leg Ulcer Healing Phase 2
Completed NCT04461132 - The Effect of Manual Lymphatic Drainage N/A
Completed NCT05974982 - Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers Phase 1
Completed NCT04011371 - Cyanoacrylate Closure for Treatment of Venous Leg Ulcers N/A
Not yet recruiting NCT03543007 - Evaluating the Safety and Efficacy of GrafixPLâ„¢PRIME for the Treatment of Chronic Venous Leg Ulcers N/A
Completed NCT03286140 - Early Venous Reflux Ablation Ulcer Trial N/A
Recruiting NCT05588583 - A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing. N/A
Not yet recruiting NCT04613687 - Efficacy and Safety of a New Compression System URGO BD001 in the Treatment of VLU (FREEDOM) N/A
Recruiting NCT05549609 - A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers Phase 1/Phase 2
Recruiting NCT05409976 - The GORE® VIAFORT Vascular Stent IVC Study N/A
Not yet recruiting NCT05089890 - Clinical Investigation of Sorbact® Dressings N/A
Not yet recruiting NCT03670329 - Management of Infection Risk in Non-comparative Trial (MINT) N/A